Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Clinical trial NCT01138163 · COMPLETED
Trial details
- NCT number
- NCT01138163
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.